Embolization of uterine fibroids beats surgery
Lower costs, speedier recovery, and reduced pain give uterine artery embolization an edge over surgery for fibroid treatment, according to a multicenter trial that examined the relative merits of the two methods.
Lower costs, speedier recovery, and reduced pain give uterine artery embolization an edge over surgery for fibroid treatment, according to a multicenter trial that examined the relative merits of the two methods.
Researchers in the Randomized Trial of Embolization versus Surgical Treatment for Fibroids (REST), including 27 U.K. hospitals, assessed quality of life up to one year post-treatment for 157 women involved in the study who had been randomized to embolization or surgery (hysterectomy or myoectomy). They found that women who had embolization-costing about $1700 less than surgery-reported significantly less pain after their procedures, had much shorter hospital stays, were able to return to work and other activities more quickly, and had fewer post-treatment major adverse events than those who underwent surgery (NEJM 2007;356[4]:360-370).
Newsletter
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Key MRI Findings Predictive of Treatment Response for Unresectable Hepatocellular Carcinoma
July 14th 2025For patients with unresectable hepatocellular carcinoma, a pre-treatment MRI finding of LI-RADS tumor in vein was associated with over an 86 percent lower likelihood of responding to transcatheter arterial chemoembolization (TACE) and targeted immunotherapy.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.
